688029 南微医学
已收盘 06-04 15:00:01
资讯
新帖
简况
每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案
证券之星 · 05-24
每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案
南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%
证券之星 · 05-21
南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%
南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%
证券之星 · 05-20
南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%
每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%
证券之星 · 05-17
每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%
南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%
证券之星 · 05-14
南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%
股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元
证券之星 · 05-06
股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元
东吴证券：给予南微医学买入评级
证券之星 · 05-04
东吴证券：给予南微医学买入评级
4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股
证券之星 · 04-28
4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股
国金证券：给予南微医学买入评级
证券之星 · 04-28
国金证券：给予南微医学买入评级
图解南微医学年报：第四季度单季净利润同比下降40.21%
证券之星 · 04-28
图解南微医学年报：第四季度单季净利润同比下降40.21%
每周股票复盘：南微医学（688029）发生1笔大宗交易成交1.32亿元
证券之星 · 04-19
每周股票复盘：南微医学（688029）发生1笔大宗交易成交1.32亿元
4月13日南微医学发生1笔大宗交易 成交金额1.32亿元
证券之星 · 04-13
4月13日南微医学发生1笔大宗交易 成交金额1.32亿元
每周股票复盘：南微医学（688029）现1749.39万元大宗交易
证券之星 · 04-05
每周股票复盘：南微医学（688029）现1749.39万元大宗交易
4月2日南微医学现1749.39万元大宗交易
证券之星 · 04-02
4月2日南微医学现1749.39万元大宗交易
南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张
美股速递 · 03-18
南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张
南微医学：公司目前生产经营一切正常，基本面稳健
证券日报 · 03-16
南微医学：公司目前生产经营一切正常，基本面稳健
3月3日南微医学跌5.19%，中庚价值先锋股票基金重仓该股
证券之星 · 03-03
3月3日南微医学跌5.19%，中庚价值先锋股票基金重仓该股
股市必读：南微医学发布2025年度业绩快报，盈利5.701亿元
证券之星 · 03-02
股市必读：南微医学发布2025年度业绩快报，盈利5.701亿元
每周股票复盘：南微医学（688029）2025年净利5.70亿增3.05%
证券之星 · 03-01
每周股票复盘：南微医学（688029）2025年净利5.70亿增3.05%
南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”
证券之星 · 01-31
南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”
加载更多
公司概况
公司名称：
南微医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜耗材类产品、肿瘤介入类产品、可视化类产品。公司被国家工业和信息化部认定为制造业单项冠军企业。
发行价格：
52.45
{"stockData":{"symbol":"688029","market":"SH","secType":"STK","nameCN":"南微医学","latestPrice":72.98,"timestamp":1780556401000,"preClose":75.88,"halted":0,"volume":1358346,"delay":0,"changeRate":-0.0382,"floatShares":188000000,"shares":188000000,"eps":2.9591,"marketStatus":"已收盘","change":-2.9,"latestTime":"06-04 15:00:01","open":75.88,"high":76.2,"low":72.7,"amount":100000000,"amplitude":0.0461,"askPrice":72.98,"askSize":20,"bidPrice":72.96,"bidSize":4,"shortable":0,"etf":0,"ttmEps":2.9591,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780623000000},"marketStatusCode":5,"adr":0,"adjPreClose":75.88,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780536600000,1780543800000],[1780549200000,1780556400000]],"highLimit":83.47,"lowLimit":68.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":187847422,"isCdr":false,"pbRate":3.23,"roa":"--","peRate":24.662904,"roe":"3.5%","epsLYR":3.05,"committee":-0.774194,"marketValue":13709000000,"turnoverRate":0.0072,"status":1,"afterMarket":{"amount":0,"volume":0,"close":72.98,"buyVolume":0,"sellVolume":0,"time":1780558438866,"indexStatus":"已收盘 06-04 15:30:00","preClose":75.88},"floatMarketCap":13709000000},"requestUrl":"/m/hq/s/688029","defaultTab":"news","newsList":[{"id":"2637337599","title":"每周股票复盘：南微医学（688029）召开2025年度股东会，通过利润分配等八项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2637337599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637337599?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:38","pubTimestamp":1779565091,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，南微医学报收于80.42元，较上周的82.28元下跌2.26%。本周关注点公司公告汇总：南微医学召开2025年度股东会，审议通过2025年度利润分配方案等八项议案。公司公告汇总：江苏新高的律师事务所确认南微医学2025年年度股东会会议程序合法有效。江苏新高的律师事务所出具法律意见书，见证南微医学科技股份有限公司2025年年度股东会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637810223","title":"南微医学（688029）披露2025年度暨2026年第一季度中英双语业绩说明会召开时间调整公告，5月21日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637810223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637810223?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:50","pubTimestamp":1779357044,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，南微医学报收于80.78元，较前一交易日下跌0.09%，最新总市值为151.74亿元。近日，南微医学科技股份有限公司发布《关于2025年度暨2026年第一季度中英双语业绩说明会召开时间调整的公告》。公告显示，公司决定将原定于2026年5月27日下午14:30-15:30召开的业绩说明会，调整为15:00-16:00举行。会议将以直播及网络文字互动形式进行，平台为上证路演中心。会议结束后，投资者可通过上证路演中心查看会议回放。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636184868","title":"南微医学（688029）披露2025年年度股东会决议公告，5月20日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636184868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636184868?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:43","pubTimestamp":1779270193,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，南微医学报收于80.85元，较前一交易日下跌0.77%，最新总市值为151.87亿元。南微医学科技股份有限公司于2026年5月20日披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月19日在南京江北新区药谷大道199号召开2025年年度股东会，会议由董事会召集，董事长隆晓辉主持，采用现场与网络投票结合方式举行。出席会议股东及代理人共145人，代表有表决权股份总数110,472,084股，占公司总表决权股份的59.2007%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636064672","title":"每周股票复盘：南微医学（688029）2025年营收31.84亿增15.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636064672","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636064672?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:16","pubTimestamp":1778958972,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，南微医学报收于82.28元，较上周的83.0元下跌0.87%。本周，南微医学5月13日盘中最高价报86.3元。本周关注点公司公告汇总：南微医学2025年营业总收入31.84亿元，同比增长15.55%公司公告汇总：完成收购西班牙CME公司51%股权，启用泰国制造中心公司公告汇总：海外业务收入占比提升至60%公司公告汇总南微医学科技股份有限公司2025年年度股东会会议资料显示，2025年公司营业总收入31.84亿元，同比增长15.55%；归母净利润5.70亿元，同比增长3.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635713500","title":"南微医学（688029）披露2025年年度股东会会议资料，5月14日股价下跌3.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635713500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635713500?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:53","pubTimestamp":1778752393,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，南微医学报收于82.66元，较前一交易日下跌3.68%，最新总市值为155.27亿元。该股当日开盘85.88元，最高86.28元，最低82.66元，成交额达1.36亿元，换手率为0.86%。公司于近日披露《南微医学科技股份有限公司2025年年度股东会会议资料》。公司营业总收入31.84亿元，同比增长15.55%；归母净利润5.70亿元，同比增长3.09%。全年召开7次董事会、4次股东大会，审议40项议案，决策程序合规高效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400033962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633356925","title":"股市必读：4月30日南微医学现1笔折价10.88%的大宗交易 合计成交4796.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633356925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633356925?lang=zh_cn&edition=full","pubTime":"2026-05-06 03:50","pubTimestamp":1778010619,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，南微医学报收于85.02元，上涨1.38%，换手率1.42%，成交量2.67万手，成交额2.26亿元。交易信息汇总资金流向4月30日主力资金净流入1094.85万元，占总成交额4.85%；游资资金净流入1733.67万元，占总成交额7.68%；散户资金净流出2828.52万元，占总成交额12.53%。大宗交易4月30日南微医学发生1笔折价10.88%的大宗交易，合计成交4796.24万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632931530","title":"东吴证券：给予南微医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2632931530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632931530?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:05","pubTimestamp":1777885526,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对南微医学进行研究并发布了研究报告《2025年报&2026一季报点评：国际市场表现亮眼，创新产品快速增长》，给予南微医学买入评级。26Q1海外收入占总收入比例提升至61.26%。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为97.8。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050400003632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630750403","title":"4月28日南微医学涨10.70%，中庚价值先锋股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630750403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630750403?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:25","pubTimestamp":1777364705,"startTime":"0","endTime":"0","summary":"证券之星消息，4月28日南微医学涨10.70%，收盘报83.88元，换手率3.64%，成交量6.84万手，成交额5.63亿元。重仓南微医学的前十大公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为97.65。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为中庚基金的中庚价值先锋股票。该公募基金现任基金经理为陈涛。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800048864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630448753","title":"国金证券：给予南微医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630448753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630448753?lang=zh_cn&edition=full","pubTime":"2026-04-28 08:35","pubTimestamp":1777336558,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对南微医学进行研究并发布了研究报告《海外业务高增长，汇兑扰动短期业绩》，给予南微医学买入评级。其中，一次性内镜步入良性发展轨道，海外销售表现亮眼，美洲市场实现翻倍增长，欧洲区域同比增幅超70%；国内终端销量稳步攀升，业务发展迈入良性循环。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为97.65。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800027564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630331980","title":"图解南微医学年报：第四季度单季净利润同比下降40.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630331980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630331980?lang=zh_cn&edition=full","pubTime":"2026-04-28 00:59","pubTimestamp":1777309148,"startTime":"0","endTime":"0","summary":"证券之星消息，南微医学2025年年报显示，当年度公司主营收入31.84亿元，同比上升15.55%；归母净利润5.7亿元，同比上升3.09%；扣非净利润5.52亿元，同比上升1.44%；其中2025年第四季度，公司单季度主营收入8.03亿元，同比上升8.11%；单季度归母净利润6106.34万元，同比下降40.21%；单季度扣非净利润4408.77万元，同比下降55.11%；负债率20.53%，投资收益1694.2万元，财务费用-6603.76万元，毛利率64.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628175951","title":"每周股票复盘：南微医学（688029）发生1笔大宗交易成交1.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628175951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628175951?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:37","pubTimestamp":1776537427,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，南微医学（688029）报收于73.54元，较上周的80.01元下跌8.09%。本周，南微医学4月13日盘中最高价报79.99元。4月17日盘中最低价报73.19元。南微医学当前最新总市值138.14亿元，在医疗器械板块市值排名19/129，在两市A股市值排名1525/5198。本周关注点交易信息汇总：4月13日南微医学发生1笔大宗交易，成交金额1.32亿元交易信息汇总4月13日南微医学发生1笔大宗交易，成交金额1.32亿元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627543610","title":"4月13日南微医学发生1笔大宗交易 成交金额1.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627543610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627543610?lang=zh_cn&edition=full","pubTime":"2026-04-13 17:20","pubTimestamp":1776072034,"startTime":"0","endTime":"0","summary":"证券之星消息，4月13日南微医学发生大宗交易，交易数据如下：大宗交易成交价格76.49元，相对当日收盘价溢价1.7%，成交172.9万股，成交金额13225.2万元，买方营业部为中国国际金融股份有限公司上海分公司，卖方营业部为中国国际金融股份有限公司上海分公司。近三个月该股共发生3笔大宗交易，合计成交1.96万手，折价成交2笔，溢价成交1笔。截至2026年4月13日收盘，南微医学报收于75.21元，下跌6.0%，换手率1.39%，成交量2.61万手，成交额2.0亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300022558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625619826","title":"每周股票复盘：南微医学（688029）现1749.39万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2625619826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625619826?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:43","pubTimestamp":1775328189,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，南微医学（688029）报收于74.15元，较上周的72.58元上涨2.16%。本周，南微医学4月2日盘中最高价报76.38元。3月30日盘中最低价报71.11元。南微医学当前最新总市值139.29亿元，在医疗器械板块市值排名18/129，在两市A股市值排名1396/5193。本周关注点来自交易信息汇总：南微医学4月2日发生1749.39万元大宗交易交易信息汇总4月2日南微医学现1749.39万元大宗交易以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624577825","title":"4月2日南微医学现1749.39万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624577825?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:27","pubTimestamp":1775122034,"startTime":"0","endTime":"0","summary":"证券之星消息，4月2日南微医学发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交2340.0手，折价成交2笔。该股近期无解禁股上市。截至2026年4月2日收盘，南微医学(688029)报收于75.21元，上涨0.7%，换手率1.03%，成交量1.93万手，成交额1.45亿元。该股近半年内有股东持股变动，合计净减持6.2万股，股东增减持明细如下表：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为97.65。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200029996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167551238","title":"南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1167551238","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167551238?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:03","pubTimestamp":1773842601,"startTime":"0","endTime":"0","summary":"南微医学已签署最终协议，收购Conmed Corporation旗下的Duraclip、Precisor及Optibite三条产品线。此次交易标志着南微医学在内窥镜耗材领域的一次重要战略布局，具体交易金额与交割时间等细节尚未披露。南微医学此次收购Conmed部分产品线，符合其通过外部并购强化核心业务竞争力的战略路径。市场关注此次收购对南微医学财务结构及盈利能力的潜在影响。尽管交易对价未公开，但整合Conmed成熟产品线预计将带来即时的收入贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","CNMD","688029","LU1815336091.USD","BK4082","LU0757428866.USD","LU1878469433.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619646294","title":"南微医学：公司目前生产经营一切正常，基本面稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2619646294","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619646294?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:09","pubTimestamp":1773670140,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月16日，南微医学在互动平台回答投资者提问时表示，二级市场股价受宏观政策、行业环境、投资者预期等多重因素影响。公司目前生产经营一切正常，基本面稳健，各项业务有序推进。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-16/doc-inhrezkm8666144.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-16/doc-inhrezkm8666144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616312111","title":"3月3日南微医学跌5.19%，中庚价值先锋股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616312111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616312111?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:32","pubTimestamp":1772526767,"startTime":"0","endTime":"0","summary":"证券之星消息，3月3日南微医学跌5.19%创60日新低，收盘报72.3元，换手率2.7%，成交量5.07万手，成交额3.7亿元。重仓南微医学的前十大公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为97.65。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共33家，其中持有数量最多的公募基金为中庚基金的中庚价值先锋股票。该公募基金现任基金经理为陈涛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300028925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616757508","title":"股市必读：南微医学发布2025年度业绩快报，盈利5.701亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616757508","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616757508?lang=zh_cn&edition=full","pubTime":"2026-03-02 02:33","pubTimestamp":1772389990,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，南微医学报收于82.53元，下跌0.17%，换手率0.68%，成交量1.27万手，成交额1.05亿元。业绩披露要点业绩快报南微医学近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润盈利5.701亿元，同比增长3.05%。公司公告汇总南微医学科技股份有限公司2025年度业绩快报公告南微医学科技股份有限公司发布2025年度业绩快报，营业总收入319,093.19万元，同比增长15.81%；归属于母公司所有者的净利润57,011.40万元，同比增长3.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616843067","title":"每周股票复盘：南微医学（688029）2025年净利5.70亿增3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843067","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843067?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:24","pubTimestamp":1772303052,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，南微医学报收于82.53元，较上周的79.27元上涨4.11%。本周，南微医学2月27日盘中最高价报84.13元。南微医学当前最新总市值155.03亿元，在医疗器械板块市值排名19/129，在两市A股市值排名1428/5189。本周关注点业绩披露要点：南微医学2025年归母净利润5.701亿元，同比增长3.05%。公司公告汇总南微医学科技股份有限公司发布2025年度业绩快报，营业总收入319,093.19万元，同比增长15.81%；归属于母公司所有者的净利润57,011.40万元，同比增长3.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607022753","title":"南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2607022753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607022753?lang=zh_cn&edition=full","pubTime":"2026-01-31 06:45","pubTimestamp":1769813140,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示南微医学（688029）公布了一项国际专利申请，专利名为“内窥镜用引流装置和引流方法”，专利申请号为PCT/CN2025/109868，国际公布日为2026年1月29日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来南微医学已公布的国际专利申请1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了8828.23万元，同比增26.88%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013100005146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780588537271,"stockEarnings":[{"period":"1week","weight":-0.0656},{"period":"1month","weight":-0.1075},{"period":"3month","weight":0.0315},{"period":"6month","weight":-0.0465},{"period":"1year","weight":0.146},{"period":"ytd","weight":-0.0696}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0069},{"period":"3month","weight":-0.006},{"period":"6month","weight":0.0464},{"period":"1year","weight":0.2148},{"period":"ytd","weight":0.029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南微医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"11634人(较上一季度减少0.74%)","perCapita":"16146股","listingDate":"2019-07-22","address":"江苏省南京市浦口区高新开发区高科三路10号","registeredCapital":"18784万元","survey":" 南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜耗材类产品、肿瘤介入类产品、可视化类产品。公司被国家工业和信息化部认定为制造业单项冠军企业。","listedPrice":52.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南微医学,688029,南微医学股票,南微医学股票老虎,南微医学股票老虎国际,南微医学行情,南微医学股票行情,南微医学股价,南微医学股市,南微医学股票价格,南微医学股票交易,南微医学股票购买,南微医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}